These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18274315)

  • 1. Optimizing the use of 17P in pregnant managed Medicaid members.
    Mason MV; House KM; Linehan J; Speers CA; Joseph LM; Littlejohn R
    Manag Care; 2008 Jan; 17(1):47-52. PubMed ID: 18274315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 17P usage on NICU admissions in a managed medicaid population--a five-year review.
    Mason MV; Poole-Yaeger A; Krueger CR; House KM; Lucas B
    Manag Care; 2010 Feb; 19(2):46-52. PubMed ID: 20550052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17 alpha-hydroxyprogesterone caproate (17P) usage in a Medicaid managed care plan and reduction in neonatal intensive care unit days.
    Mason MV; House KM; Fuest CM; Fitzgerald DR; Kitson BJ; Inglis JA
    Manag Care; 2005 Oct; 14(10):58-63. PubMed ID: 16277194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States.
    Petrini JR; Callaghan WM; Klebanoff M; Green NS; Lackritz EM; Howse JL; Schwarz RH; Damus K
    Obstet Gynecol; 2005 Feb; 105(2):267-72. PubMed ID: 15684150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes of managed Medicaid members prescribed home administration of 17 α-hydroxyprogesterone caproate.
    Lucas B; Poole-Yaeger A; Istwan N; Stanziano G; Rhea D; Mason M
    Am J Perinatol; 2012 Aug; 29(7):489-96. PubMed ID: 22399213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
    González-Quintero VH; Istwan NB; Rhea DJ; Smarkusky L; Hoffman MC; Stanziano GJ
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):249-52. PubMed ID: 17437227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate.
    Rebarber A; Ferrara LA; Hanley ML; Istwan NB; Rhea DJ; Stanziano GJ; Saltzman DH
    Am J Obstet Gynecol; 2007 Mar; 196(3):224.e1-4. PubMed ID: 17346529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
    Rebarber A; Istwan NB; Russo-Stieglitz K; Cleary-Goldman J; Rhea DJ; Stanziano GJ; Saltzman DH
    Diabetes Care; 2007 Sep; 30(9):2277-80. PubMed ID: 17563346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C; Sullivan S; Istwan N; Rhea D; Stanziano G; Newman R
    Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery.
    Sibai B; Meis PJ; Klebanoff M; Dombrowski MP; Weiner SJ; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S;
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1181-6. PubMed ID: 16157134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population.
    Newman RB; Sullivan SA; Menard MK; Rittenberg CS; Rowland AK; Korte JE; Kirby H
    Am J Obstet Gynecol; 2008 Oct; 199(4):393.e1-8. PubMed ID: 18928985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of maternal body mass on the effectiveness of 17 alpha-hydroxyprogesterone caproate.
    Ventolini G; Duke J; Po W; Barhan S; Rhea D; Desch C; Istwan N; Stanziano G
    J Reprod Med; 2008 Sep; 53(9):667-71. PubMed ID: 18839818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in neonatal intensive care unit admission rates in a Medicaid managed care program.
    Stankaitis JA; Brill HR; Walker DM
    Am J Manag Care; 2005 Mar; 11(3):166-72. PubMed ID: 15786855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.
    Rittenberg C; Sullivan S; Istwan N; Rhea D; Stanziano G; Newman R
    Am J Obstet Gynecol; 2007 Sep; 197(3):262.e1-4. PubMed ID: 17826412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
    Sibai BM; Istwan NB; Palmer B; Stanziano GJ
    Am J Perinatol; 2012 Sep; 29(8):635-42. PubMed ID: 22576126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are outcomes and care processes for preterm neonates influenced by health insurance status?
    Brandon GD; Adeniyi-Jones S; Kirkby S; Webb D; Culhane JF; Greenspan JS
    Pediatrics; 2009 Jul; 124(1):122-7. PubMed ID: 19564291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-alphahydroxyprogesterone caproate in women with previous spontaneous preterm delivery: does a previous term delivery affect the rate of recurrence?
    Barton JR; Barton LA; Istwan NB; Rhea DJ; Desch CN; Sibai BM
    Am J Obstet Gynecol; 2011 Sep; 205(3):269.e1-6. PubMed ID: 22071060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal treatment in pregnant women improves periodontal disease but does not alter rates of preterm birth.
    López R
    Evid Based Dent; 2007; 8(2):38. PubMed ID: 17589481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance.
    Rittenberg C; Newman RB; Istwan NB; Rhea DJ; Stanziano GJ
    J Reprod Med; 2009 Feb; 54(2):47-52. PubMed ID: 19301566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.